Apimeds Pharmaceuticals US APUS
NYSE APUS
$3.51 +0.10 (+2.93%)
As of: Oct 21, 2026 · 9:46 AM EDT

Apimeds Pharmaceuticals US (APUS) Retained Earnings (2023 - 2026)

Updated

Apimeds Pharmaceuticals US (APUS) posted Retained Earnings of -$65.63 million for Q2 2026, compared with -$7.46 million a year earlier.

Analysis

Apimeds Pharmaceuticals US (APUS) Retained Earnings (2023 - 2026) Analysis & Trends

At the end of FY2025, Apimeds Pharmaceuticals US's Retained Earnings came in at -$10.39 million.

  • In prior years, Apimeds Pharmaceuticals US's Retained Earnings was -$4.39 million in FY2024 and -$3 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Eli Lilly 1,137.84 Bn 1,106.42 Bn 19.71 Bn 31.89 Bn
2 Johnson & Johnson 618.03 Bn 536.55 Bn 17.26 Bn 171.67 Bn
3 AbbVie 507.69 Bn 480.80 Bn 12.70 Bn -17.33 Bn
4 Merck 366.91 Bn 321.28 Bn 12.21 Bn 63.27 Bn
5 Novartis Ag 298.54 Bn 262.53 Bn 11.24 Bn -
6 Astrazeneca 263.16 Bn 236.84 Bn 12.86 Bn 12.59 Bn
7 Amgen 236.31 Bn 191.71 Bn 7.24 Bn -22.28 Bn
8 Gilead Sciences 192.91 Bn 167.11 Bn 6.22 Bn 2.20 Bn
9 Pfizer 171.40 Bn 118.04 Bn 10.94 Bn 112.09 Bn
10 Apimeds Pharmaceuticals US 6.01 Mn -13.62 Mn - -65.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -65.63 Mn
Dec 31, 2025 -10.39 Mn
Sep 30, 2025 -9.24 Mn
Jun 30, 2025 -7.46 Mn
Mar 31, 2025 -4.79 Mn
Dec 31, 2024 -4.39 Mn
Dec 31, 2023 -3.00 Mn
API Access

Apimeds Pharmaceuticals US Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=APUS&period=max&api_key=YOUR_API_KEY